Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue

REFERENCES

• Abolfazli, R., Hosseini, M., Ghanizadeh, A., Ghaleiha, A., Tabrizi, M., Raznahan, M., . . . Akhondzadeh, S. (2011). Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Depression & Anxiety, 28, 297–302.
   PubMed Web of Science ®Google Scholar
• Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003). Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Movement Disorders, 18, 287–293.
   PubMed Web of Science ®Google Scholar
• Albert, S., & Rabkin, J. (2008). General health status, functioning and disability measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 107–123). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Al-Khindi, T., Zakzanis, K., & van Gorp, W. (2012). Does antiretroviral therapy improve HIV-associated cognitive impairment? Journal of the International Neuropsychological Society, 17, 956–969.
   Google Scholar
• Antinori, A., Arendt, G., Becker, J., Brew, B., Byrd, D., Cherner, M., . . . Wojna, V. E. (2007). Updated research criteria for HIV-associated neurocognitive disorders. Neurology, 69, 1789–1799.
   PubMed Web of Science ®Google Scholar
• Ballon, J., & Feifel, D. (2006). A systematic review of modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry, 67, 554–566.
   PubMed Web of Science ®Google Scholar
• Barroso, J., Hammill, B., Leserman, J., Salahuddin, N., Harmon, J., & Pence, B. (2010). Physiological and psychosocial factors that predict HIV related fatigue. AIDS Behavior, 14, 1415–1427.
   PubMed Web of Science ®Google Scholar
• Broadbent, D. E., Cooper, P. F., Fitzgerald, P., & Parkes, K. (1982). The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21, 1016.
   Web of Science ®Google Scholar
• Brown, G. R. (1995). The use of methylphenidate for cognitive decline associated with HIV disease: Stimulant use in consultation patients. International Journal of Psychiatry in Medicine, 25, 21–37.
   PubMed Web of Science ®Google Scholar
• Cooper, M., Bird, H., & Steinberg, M. (2009). Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Annals of Pharmacotherapy, 43, 721–725.
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Franklin, D., Abramson, I., Ellis, R. J., Letendre, S., Collier, A., . . . Heaton, R. (2011). Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. Journal of Clinical & Experimental Neuropsychology, 33, 505–522.
   PubMed Web of Science ®Google Scholar
• DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, L. R., & Poirer, J. A. (2004). Prospective trial of modafinil as an adjunctive treatment of major depression. Journal of Clinical Psychopharmacology, 24, 87–90.
   PubMed Web of Science ®Google Scholar
• D’Elia, L., Satz, P., Uchiyama, C., & White, T. (1996). Color Trails Test. Odessa, FL: Psychological Assessment Resources.
   Google Scholar
• Devlin, K., Gongvatana, A., Clark, U., Chasman, J., Westbrook, M., Tashima, K., . . . Cohen, R. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of the International Neuropsychological Society, 18, 68–78.
   PubMed Web of Science ®Google Scholar
• Dinges, D. F., & Weaver, T. (2003). Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Medicine, 4, 393–402.
   PubMed Web of Science ®Google Scholar
• Durvasula, R., Norman, L., & Malow, R. (2009). Current perspectives on the neuropsychology of HIV. In C. Pope, R. White, & R. Malow (Eds.), HIV/AIDS: Global frontiers in prevention/intervention (pp. 177–190). New York, NY: Routledge.
   Google Scholar
• Golden, C. J. (1978). Stroop Word and Color Test: A manual for clinical and experimental uses. Chicago, IL: Stoetling.
   Google Scholar
• Harsh, J. R., Hayduk, R., Rosenberg, R., Wesnes, K., Walsh, J., Arora, S., . . . Roth, T. (2006). The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Current Medical Research and Opinions, 22, 761–774.
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Clifford, D. B., Franklin, D., Jr., Woods, S. P., Ake, C., Vaida, F., . . . Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter Study. Neurology, 75, 2087–2096.
   PubMed Web of Science ®Google Scholar
• Hinkin, C., Castellon, S., Hardy, D. F., Farinpour, R., Newton, T., & Singer, E. (2001). Methylphenidate improves HIV-associated cognitive slowing. Journal of Neuropsychiatry & Clinical Neuroscience, 13,248–254.
   PubMed Web of Science ®Google Scholar
• Hirshkowitz, M., Black, J., Wesnes, K., Niebler, G., Arora, S., & Roth, T. (2007). Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respiratory Medicine, 101, 616–627.
   PubMed Web of Science ®Google Scholar
• Jenkin, P., Koch, T., & Kralik, D. (2006). The experience of fatigue for adults living with HIV. Journal of Clinical Nursing, 15, 1123–1131.
   PubMed Web of Science ®Google Scholar
• Jong, E., Oudhoff, L., Epskamp, C., Wagener, M., Van Duijn, M., Fischer, S., & Van Gorp, E. (2010). Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral era. AIDS, 24, 1387–1405.
   PubMed Web of Science ®Google Scholar
• Koback, K., Skodol, A., & Bender, D. (2008). Diagnostic measures for adults. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 35–60). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Krupp, L., LaRocca, N., Muir-Nash, J., & Steinberg, A. (1989). The Fatigue Severity Scale. Archives of Neurology, 46, 1121–1123.
   PubMed Web of Science ®Google Scholar
• Maj, M., D’Elia, L., Satz, P., Janssen, R., Zaudig, M., & Uchiyama, C. (1993). Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: The WHO Study. Archives of Clinical Neuropsychology, 8, 123–135.
   PubMed Web of Science ®Google Scholar
• Matthews, C., & Klove, H. (1964). Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
   Google Scholar
• McElhiney, M., Rabkin, J., van Gorp, W., & Rabkin, R. (2010). Modafinil effects on cognitive function in HIV+ patients treated for fatigue: A placebo controlled study. Journal of Clinical & Experimental Neuropsychology, 32, 474–480.
   PubMed Web of Science ®Google Scholar
• Mitrushina, M. N., Boone, K. B., & D’Elia, L. F. (1999). Handbook of normative data for neuropsychological assessment. New York, NY: Oxford University Press.
   Google Scholar
• Rabkin, J., Gordon, P., McElhiney, M., Rabkin, R., Chew, S., & Mitsumoto, H. (2009). Modafinil treatment of fatigue in patients with ALS: A placebo controlled study. Muscle & Nerve, 39, 297–303.
   PubMed Web of Science ®Google Scholar
• Rabkin, J., McElhiney, M., & Rabkin, R. (2011). Treatment of HIV-related fatigue with armodafinil: A placebo controlled randomized trial. Psychosomatics, 52, 328–336.
   PubMedGoogle Scholar
• Rammohan, K., Rosenberg, J., Lynn, D., Blumenfeld, A., Pollak, C., & Nagaraja, H. (2002). Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two-centre Phase 2 study. Journal of Neurology, Neurosurgery & Psychiatry, 72, 179–183.
   PubMed Web of Science ®Google Scholar
• Randall, D. C., Shneerson, J., Plaha, K., & File, S. (2002). Modafinil affects mood, but not cognitive function, in healthy young volunteers. Human Psychopharmacology, 18, 163–173.
   Web of Science ®Google Scholar
• Schouten, J., Cinque, P., Gisslen, M., Reiss, P., & Portegies, P. (2011). HIV-1 and cognitive impairment in the cART era: A review. AIDS, 25, 561–575.
   PubMed Web of Science ®Google Scholar
• Spreen, O., & Strauss, E.(1998). A compendium of neuropsychological tests (2nd ed.). New York, NY: Oxford University Press.
   Google Scholar
• Urbano, F., Leznik, E., & Llinas, R. (2007). Modafinil enhances thalamocortical activity by increasing neuronal electronic coupling. PNAS, 104, 12554–12559.
   PubMed Web of Science ®Google Scholar
• Valcour, V. (2011). Evaluating cognitive impairment in the clinical setting: Practical screening and assessment tools. Topics in Antiviral Medicine, 19, 175–180.
   PubMedGoogle Scholar
• Volkow, N., Fowler, J., Logan, J., Alexoff, D., Zhu, W., Telang, F., . . . Apelskog-Torres, K. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. Journal of the American Medical Association, 301, 1148–1154.
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1997). Wechsler Adult Intelligence Scale–Third Edition (WAIS–III). San Antonio, TX: The Psychological Corporation.
   Google Scholar
• Williams, J. B. W. (2008). Mental health status, functioning and disabilities measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 83–105). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychological Review, 19, 152–168.
   PubMed Web of Science ®Google Scholar
• Wright, E. (2011). Neurocognitive impairment and neuroCART. Current Opinions in HIV and AIDS, 6, 303–308.
   PubMedGoogle Scholar
• Yonkers, K., & Samson, J. (2008). Mood disorders measures. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 499–528). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Young, J., & Geyer, M. (2010). Action of modafinil—Increased motivation via the dopamine transporter inhibition and D1 receptors? Biological Psychiatry, 67, 784–787.
   PubMed Web of Science ®Google Scholar